From the No. 1 Scholar in the College Entrance Examination to the Technology Overlord

Tianfang Pharmaceutical’s original main drug products belong to cell pharmaceuticals.

Therefore, the equipment required in cell medicine is available.

The anti-cancer drugs that Jiangcheng wants to develop are not difficult for Jiangcheng, and in essence, it can also be regarded as a cell pharmaceutical process.

The traditional cell pharmaceutical process is to use cell biology, molecular biology and other theories and technologies as a unit, purposefully and carefully designed, carefully operated, so that some genetic characteristics of cells are changed, to achieve the purpose of improving or producing new varieties, and to make cells increase or regain the ability to produce a specific product, so as to carry out a large number of culture, proliferation, and extract products useful to human beings under ex vivo conditions.

Humans can use cells from animals and plants to make drugs.

However, the process of Jiangcheng’s anti-cancer drugs is several grades higher than that of traditional cell medicine.

In fact, in real life, there are many things that can effectively prevent and kill cancer cells, but why anti-cancer drugs have not made substantial progress.

The main reason is that human beings still have no mastery of being able to completely combine and fuse these things that can kill cancer cells and use them.

Whether the desired cells are taken from animals or plants, if they cannot be achieved by some technologies, they will destroy the structure of the cells, damage their characteristics, and the technology of fusion transformation is not mature.

Therefore, even if the required medium is eventually extracted, there is still no way to effectively apply it to the clinic.

These technologies have not been fully mastered by mankind so far.

Inside the laboratory on the second floor.

Jiang Cheng has debugged all the instruments and equipment, and all of them are good to use.

On the laboratory table, the pharmaceutical raw materials bought by Jiang Cheng include bitter melon, kiwi fruit, wheat bran, radish, and kelp.

It can be said that they are all very ordinary ingredients and fruits, which are far worse than the noble things such as anti-cancer drugs.

However, if people engaged in related medical professions actually understand that most of the drugs they are exposed to clinically come from ordinary sources, they are some basic animals and plants.

It’s just that extracting substances from animals and plants and converting them into drugs is a technical process.

The five raw materials of bitter melon, kiwifruit, wheat bran, radish and kelp have the anti-cancer substances needed by Jiangcheng.

The anti-cancer effect of bitter melon comes from a quinine-like protein, which is an active protein that activates immune cells, and kills cancer cells or other abnormal cells through immune cells as a “setter”.

Kiwi: The highest vitamin C content of fruits.

Wheat bran: the best anti-cancer dietary fiber, can prevent and treat colorectal cancer, diabetes, hypercholesterolemia, hyperlipidemia, constipation, hemorrhoids, etc.

Radish contains a variety of enzymes that can eliminate the carcinogenic effect of nitrosamines, the essence of which can stimulate body immunity, improve the activity of macrophages, and enhance their ability to engulf and kill cancer cells.

The traditional Chinese medicine of kelp is called “kelp”, which prevents breast cancer and thyroid tumors.

Cancer cells belong to a kind of cells of the human body, everyone has proto-oncogenes and tumor suppressor genes in the body, but not everyone has cancer cells in the body, proto-oncogenes are responsible for the cycle of cell division and proliferation, and human growth needs it.

But when it mutates, it becomes cancerous.

The mechanism of anti-cancer drugs studied by Jiang Cheng is to effectively prevent them, and the other is to kill cancer cells as soon as they appear.

Using these anti-cancer raw materials that have specific mechanisms for cancer cells, after taking the anti-cancer drugs developed by him, humans can promote the production of a new type of anti-cancer target cells in the body, and have always existed in the human body to become a guard who monitors cancer cells all the time.

Once cancer cells appear in the human body, they are killed as soon as possible, and there are no side effects themselves.

Such an effective anti-cancer drug is absolutely everyone’s dream, but because the technology is not enough, it has not been developed.

But this is not difficult for Jiang Cheng.

Soon, Jiang Cheng buried his head in the research room and used the biotechnology he had mastered to start the production of anti-cancer drugs.

The equipment in the laboratory began to operate.

Jiang Cheng’s figure walked back and forth in it, constantly busy.

Time passed minute by minute, Jiang Cheng was completely immersed in the process of drug development, he mastered the technology of medicine, but the first batch of experimental drugs still needed to be personally made by himself.

Then trials, non-Linchuan experiments and clinical trials, and finally approval from the State Food and Drug Administration.

Of course, this only takes a little time for Jiangcheng now.

Eight o’clock in the evening!

Call~

Chief Jiang Cheng breathed a sigh of relief, looked at the brown agent in the reagent tube, a smile appeared on his face, and it was finally done.

The brown agent in this test tube is the anti-cancer drug developed by Jiangcheng, and the drug can be directly injected intravenously.

“Before a clinical trial, a few more non-clinical trials are needed.” Jiang Cheng said secretly.

The first non-clinical trial is to test whether the anti-cancer drug is effective on cancer cells, and to test whether the drug will have side effects when used in humans.

If there is a problem with either of them, the anti-cancer drug is a failure.

Moreover, after all non-clinical trials are qualified, in terms of formal procedures, Jiangcheng also needs to apply to the Food and Drug Administration to conduct clinical trials of anticancer drugs, and only after all are qualified can the drugs be mass-produced and put into use.

According to the current national control policy on drugs, it can be said that this series of things is not simple.

But for Jiang Cheng, it’s different, who let him have a relationship!

His grand consultant to the Institute of Biology of the Chinese Academy of Sciences was not for nothing.

He has already thought about how to publish his anti-cancer drugs reasonably and effectively.

ps: The seventh change, ask for automatic subscription, ask for confirmation, there are still three changes left, but it will definitely not only update three changes, it will always be updated, just hope that the brothers can subscribe to give strength, seek full determination.